Children With Short Stature Display Reduced ACE2 Expression in Peripheral Blood Mononuclear Cells
- PMID: 35909539
- PMCID: PMC9335146
- DOI: 10.3389/fendo.2022.912064
Children With Short Stature Display Reduced ACE2 Expression in Peripheral Blood Mononuclear Cells
Abstract
Background: The cause of short stature remains often unknown. The renin-angiotensin system contributes to growth regulation. Several groups reported that angiotensin-converting enzyme 2 (ACE2)-knockout mice weighed less than controls. Our case-control study aimed to investigate if children with short stature had reduced ACE2 expression as compared to controls, and its significance.
Materials and methods: children aged between 2 and 14 years were consecutively recruited in a University Hospital pediatric tertiary care center. Cases were children with short stature defined as height SD ≤ -2 diagnosed with growth hormone deficiency (GHD) or idiopathic short stature (ISS), before any treatment. Exclusion criteria were: acute diseases, kidney disease, endocrine or autoimmune disorders, precocious puberty, genetic syndromes, SGA history. ACE and ACE2 expression were measured in peripheral blood mononuclear cells, angiotensins were measured by ELISA.
Results: Children with short stature displayed significantly lower ACE2 expression, being 0.40 fold induction (0.01-2.27) as compared to controls, and higher ACE/ACE2, with no differences between GHD and ISS. ACE2 expression was significantly and inversely associated with the risk of short stature, OR 0.26 (0.07-0.82), and it had a moderate accuracy to predict it, with an AUC of 0.73 (0.61-0.84). The cutoff of 0.45 fold induction of ACE2 expression was the value best predicting short stature, identifying correctly 70% of the children.
Conclusions: Our study confirms the association between the reduction of ACE2 expression and growth retardation. Further studies are needed to determine its diagnostic implications.
Keywords: ACE2; ANP; Renin-Angiotensin System; angiotensin; growth hormone deficiency; growth retardation; short stature.
Copyright © 2022 Tonon, Tornese, Giudici, Nicolardi, Toffoli, Barbi, Fabris and Bernardi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.J Pediatr Endocrinol Metab. 2021 Jul 22;34(10):1263-1271. doi: 10.1515/jpem-2021-0389. Print 2021 Oct 26. J Pediatr Endocrinol Metab. 2021. PMID: 34291621 Clinical Trial.
-
Comparison of the efficacy and safety of recombinant human growth hormone in treating idiopathic short stature and growth hormone deficiency in children.Growth Horm IGF Res. 2020 Aug-Oct;53-54:101331. doi: 10.1016/j.ghir.2020.101331. Epub 2020 Jul 17. Growth Horm IGF Res. 2020. PMID: 32777706
-
Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?J Pediatr Endocrinol Metab. 2012;25(7-8):651-7. doi: 10.1515/jpem-2012-0182. J Pediatr Endocrinol Metab. 2012. PMID: 23155689
-
Controversies in the definition and treatment of idiopathic short stature (ISS).J Clin Res Pediatr Endocrinol. 2009;1(3):105-15. doi: 10.4008/jcrpe.v1i3.53. Epub 2009 Feb 1. J Clin Res Pediatr Endocrinol. 2009. PMID: 21274395 Free PMC article. Review.
-
Impact of short stature on quality of life: A systematic literature review.Growth Horm IGF Res. 2021 Apr-Jun;57-58:101392. doi: 10.1016/j.ghir.2021.101392. Epub 2021 Apr 30. Growth Horm IGF Res. 2021. PMID: 33975197
Cited by
-
Preliminary Study on the Effect of a Night Shift on Blood Pressure and Clock Gene Expression.Int J Mol Sci. 2023 May 26;24(11):9309. doi: 10.3390/ijms24119309. Int J Mol Sci. 2023. PMID: 37298261 Free PMC article.
-
Immunocytochemistry Profile of Benign Thyroid Nodules Not Responding to Thermal Ablation: A Retrospective Study.Int J Endocrinol. 2023 Apr 11;2023:7951942. doi: 10.1155/2023/7951942. eCollection 2023. Int J Endocrinol. 2023. PMID: 37082757 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous